Zomedica Announces Presentation of Clinical Data in Support of New Indications for PulseVet Shock Wave Therapy at Annual Meeting of American Association of Equine Practitioners - Seite 2

Trudy Gage, Zomedica Vice President, Equine & Client Education, added, "PulseVet's electrohydraulic shock wave therapy continues to take the lead in energy-based therapeutic modalities in veterinary healthcare by pioneering its use for new indications. There are many different energy-based therapeutic options available in veterinary healthcare, but the PulseVet electrohydraulic shock wave has, by far, the most supportive evidence of clinical success."

In addition to the recent pulmonary findings, Zomedica has initiated research to explore additional benefits, from treating chronic kidney disease in cats and dogs to accelerating hoof growth in horses. One significant study being conducted by Dr. Felix Duerr at Colorado State University (CSU) is evaluating the effectiveness of shock wave therapy in slowing the progression of canine osteoarthritis. Enrollment for this study has been completed and animals will be closely monitored for 50 weeks to assess the long-term impact of the therapy.

PulseVet's shock wave therapy harnesses high-energy sound waves to stimulate cells and promote the release of healing growth factors within the body which have been shown to modulate inflammation, enhance blood flow, increase bone density, and accelerate healing.

As Zomedica maintains its position at the forefront of veterinary diagnostics and therapeutics, its commitment to advancing animal care through innovation and research remains unwavering.

About Zomedica

Based in Ann Arbor, Michigan, Zomedica (NYSE American:ZOM) is a veterinary health company creating products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. Zomedica's product portfolio includes innovative diagnostics and medical devices that emphasize patient health and practice health. Zomedica's mission is to provide veterinarians the opportunity to increase productivity and grow revenue while better serving the animals in their care. For more information, visit www.zomedica.com.

Follow Zomedica

• Email Alerts: http://investors.zomedica.com
• LinkedIn: https://www.linkedin.com/company/zomedica
• Facebook: https://m.facebook.com/zomedica
• Twitter: https://twitter.com/zomedica
• Instagram: https://www.instagram.com/zomedica_inc

Cautionary Statement Regarding Forward-Looking Statements - Safe Harbor

Except for statements of historical fact, this news release contains certain "forward-looking information" or "forward-looking statements" (collectively, "forward-looking information") within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" or "will" occur and include statements relating to our expectations regarding future results. Although we believe that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. We cannot guarantee future results, performance, or achievements. Consequently, there is no representation that the actual results achieved will be the same, in whole or in part, as those set out in the forward-looking information.